Filing Details

Accession Number:
0000914062-13-000302
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-18 08:54:20
Reporting Period:
2013-11-15
Filing Date:
2013-11-18
Accepted Time:
2013-11-18 08:54:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133416 Galectin Therapeutics Inc GALT Pharmaceutical Preparations (2834) 043562325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1260641 C James Czirr C/O Galectin Therapuetics, Inc.
4960 Peachtree Industrial Blvd. Ste. 240
Norcross GA 30071
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-15 1,000 $6.90 844,450 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,457,422 Indirect By 10X Fund, L.P.
Common Stock 179,232 Indirect By Trust
Footnotes
  1. Reporting Person is a managing member of 10X Capital Management, LLC, a Florida limited liability company acting as the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such, may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. Mr. Czirr disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.